All In MedTech

FDA Clearance Tracker · P950024-S048

CAPSURE EPICARDIAL PACING LEAD

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 24, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 24, 2013

Approved

Time to decision

258 days

Received Apr 10, 2013. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P950024-S048
Device name
CAPSURE EPICARDIAL PACING LEAD
Applicant location
Mounds View, MN
Received
Apr 10, 2013
Decided
Dec 24, 2013
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P950024

Device type

Device class
Class III

Every decision under product code NVY

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A RE-PACKAGING/RE-LABELING SITE LOCATED AT MEDTRONIC IN MEMPHIS, TENNESEE.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.